Kanagawa-ken, Japan

Jun Nakabayashi

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 2.8

ph-index = 1


Location History:

  • Kanagawa-ken, JP (2017)
  • Ashigarakami-gun, JP (2023 - 2024)

Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Jun Nakabayashi: Innovator in Pharmaceutical Technology

Introduction

Jun Nakabayashi is a notable inventor based in Kanagawa-ken, Japan. He has made significant contributions to the field of pharmaceutical technology, particularly in methods and devices that enhance the efficiency of drug development.

Latest Patents

Nakabayashi holds 4 patents that focus on innovative methods and devices. His latest patents include a feature quantity calculating method, a feature quantity calculating program, and a feature quantity calculating device. These inventions enable the accurate calculation of feature quantities that reflect the chemical properties of target structures. Additionally, he has developed a screening method, a screening program, and a screening device that facilitate the efficient screening of pharmaceutical candidate compounds. Furthermore, his compound creating method, program, and device allow for the efficient creation of three-dimensional structures of pharmaceutical candidate compounds.

Career Highlights

Jun Nakabayashi is currently employed at Fujifilm Corporation, where he continues to advance his research and development efforts. His work is pivotal in evaluating the synthetic aptitude of compounds generated or modified on computers. This includes a comprehensive method that evaluates synthetic aptitude based on atomic arrangements and their corresponding appearance frequencies.

Collaborations

Some of his notable coworkers include Kyosuke Tsumura and Shino Ohira, who contribute to the collaborative efforts in their research projects.

Conclusion

Jun Nakabayashi's innovative work in pharmaceutical technology exemplifies the impact of advanced methods and devices in drug development. His contributions are essential for the future of efficient pharmaceutical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…